Sphera Funds Management’s ProQR Therapeutics PRQR Stock Holding History

Sphera Funds Management’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-346,148	Closed	-$1.9M	–	104
2020 Q1	$1.9M	Sell	346,148 -458,852	-57%	-$3.52M	0.24%	55
2019 Q4	$7.98M	Sell	805,000 -110,000	-12%	-$857K	0.66%	29
2019 Q3	$5.27M	Buy	915,000 +445,000	+95%	+$3.55M	0.81%	39
2019 Q2	$4.28M	Buy	470,000 +280,000	+147%	+$3.3M	0.59%	53
2019 Q1	$2.63M	Sell	190,000 -150,000	-44%	-$2.24M	0.24%	81
2018 Q4	$5.37M	Sell	340,000 -58,749	-15%	-$1.08M	0.6%	40
2018 Q3	$7.72M	Sell	398,749 -95,000	-19%	-$1.01M	0.89%	26
2018 Q2	$3.6M	Sell	493,749 -164,751	-25%	-$831K	0.5%	63
2018 Q1	$2.02M	Buy	658,500 +128,500	+24%	+$413K	0.31%	76
2017 Q4	$1.71M	Hold	530,000	–	–	0.2%	104
2017 Q3	$2.57M	Buy	530,000 +200,000	+61%	+$1.04M	0.37%	73
2017 Q2	$1.72M	Hold	330,000	–	–	0.29%	89
2017 Q1	$1.65M	Buy	330,000 +130,000	+65%	+$572K	0.32%	79
2016 Q4	$980K	Buy	+200,000	New	+$1.03M	0.25%	83
2016 Q1	–	Sell	-150,000	Closed	-$1.3M	–	113
2015 Q4	$1.3M	Buy	+150,000	New	+$1.73M	0.19%	103
2015 Q1	–	Sell	-130,000	Closed	-$2.82M	–	163
2014 Q4	$2.82M	Sell	130,000 -70,000	-35%	-$1.06M	0.48%	73
2014 Q3	$3.44M	Buy	+200,000	New	+$3.2M	0.42%	55

Other funds holding PRQR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sphera Funds Management's PRQR Position: Q2 2020 in Review

Sphera Funds Management sold out of ProQR Therapeutics (PRQR) in Q2 2020, closing a stake of 346,148 shares — an estimated $1.9M sold.

Sphera Funds Management first reported a position in PRQR in Q3 2014 and held it in 17 quarters. The position peaked at $7.98M in Q4 2019. 44 funds tracked by Wall St. Rank hold PRQR as of Q2 2020.

Sphera Funds Management reported no remaining ProQR Therapeutics position as of Q2 2020 after selling out during the quarter.
Sphera Funds Management sold 346,148 ProQR Therapeutics shares in Q2 2020, an estimated $1.9M.
Sphera Funds Management first reported a position in ProQR Therapeutics in Q3 2014 and held it in 17 quarters.
Sphera Funds Management's ProQR Therapeutics position peaked at $7.98M in Q4 2019.
44 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2020.

Based on Sphera Funds Management's 13F filing for Q2 2020, filed 13 Aug 2020.